Three anticonvulsant drugs in the list of risks for newborns
.
Saved in:
| Main Author: | article Editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2023-01-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: Yu. B. Belousov, et al.
Published: (2016-05-01) -
THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CHILDREN IN CLINICAL PRACTICE
by: M. V. Leonova, et al.
Published: (2017-05-01) -
Bone Mineral Density in Patients Receiving Anticonvulsant Drugs
by: Kadir Yıldırım, et al.
Published: (2002-12-01) -
New Anticonvulsants: Interchangeability Issues and the Use of Generic Anticonvulsants in Clinical Practice
by: V. V. Arkhipov, et al.
Published: (2019-06-01) -
Anticonvulsant Profiles of Three Hemorphin-4 Analogs with Rhodamine B in Mice
by: Jana Tchekalarova, et al.
Published: (2025-05-01)